Health-related quality of life and time from diagnosis among young adult colorectal cancer survivors.

Authors

null

Kimberly Ann Miller

University of Southern California, Los Angeles, CA

Kimberly Ann Miller , Julia Stal , Phuong Gallagher , Jonathan N Kaslander , David R. Freyer , Priscilla Marin , Heinz-Josef Lenz , Joel Milam , Afsaneh Barzi

Organizations

University of Southern California, Los Angeles, CA, Colon Club, Burbank, CA, Children's Hospital Los Angeles, Los Angeles, CA, USC Norris Comprehensive Cancer Center, Los Angeles, CA, USC Keck School of Medicine Norris Comprehensive Cancer Center, Los Angeles, CA

Research Funding

Other Foundation
Aflac Children's Oncology Group

Background: Incidence of colorectal cancer (CRC) in patients under 50 years of age is rising. Quality of life in survivorship is not well-described in this population. We compared health-related quality of life (HRQoL) in CRC survivors ≤ 50 years old who were 6-18 months or 19-36 months from initial diagnosis or relapse. Methods: A cross-sectional online survey was administered in collaboration with a national organization for young CRC survivors. The Functional Assessment of Cancer Therapy (FACT-C) was used to measure HRQoL, which assesses HRQoL globally, including a CRC specific scale, and emotional, physical, social, and functional well-being domains. T-tests were conducted to compare HRQoL between survivors who were 6-18 months versus 19-36 months from diagnosis/relapse. Results: This sample (n=308) had a mean age of 33.76 SD±6.68; 201 (65.3%) were male; tumor location was colon or rectal in 41.7% and 58.3%, respectively. The majority (55.23%) were diagnosed with stage 2 disease; 98.0% were non-metastatic. 42.2% experienced relapse; 25% had an ostomy. Most survivors were 6-18 months (N=189; 61.4%) from diagnosis/relapse, and key demographics and disease characteristics did not significantly differ between those who were shorter versus longer time from diagnosis/relapse. The mean global HRQoL score was 67.3 out of a possible score of 136. Across domains, scores were low, with social well-being the highest (15.15/28) and emotional well-being the lowest (11.44/24). Social well-being was significantly higher among survivors who were 6-18 months from diagnosis/relapse compared to those 19-36 months (15.98 for 6-18 months vs. 13.83 for 19-36; p<0.01), as was functional well-being (13.20 for 6-18 months vs. 11.12 for 19-36; p<0.01). Emotional well-being and physical well-being did not significantly differ between groups. Conclusions: Overall HRQoL scores were low among younger CRC survivors, and social and functional well-being were significantly worse for those longer from diagnosis. Appropriate counseling and other targeted interventions are necessary to maintain HRQoL over time in this at-risk population.

Means and T-tests to compare HRQoL among colorectal cancer survivors age 50 and under (N=308).

Total 6-18 mos dx
N=189
19-36 mos dx
N=119
Mean (SD)95% CIMean (SD)Mean (SD)t
FACT-C Global (0-136)67.34 (19.23)65.18-69.50**68.91 (17.99)64.86 (20.87)-1.80
Colorectal cancer scale (0-28)14.20 (3.23)13.84-14.56**14.48 (3.27)13.76 (3.13)-1.86
Physical well-being (0-28)14.17 (5.76)13.53-14.82**13.90 (4.97)14.61 (6.82)1.05
Social well-being (0-28)15.15 (5.46)14.54-15.76**15.98 (4.87)13.83 (6.06)-3.41**
Emotional well-being (0-24)11.44 (4.47) 10.94-11.94 **11.38 (4.37)11.54 (4.64)0.31
Functional well-being (0-28)12.40 (5.53)11.78-13.02**13.20 (5.43)11.12 (5.46)-3.26**

*p<0.05; **p<0.01

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2021 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Colorectal Cancer

Track

Colorectal Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 39, 2021 (suppl 3; abstr 34)

DOI

10.1200/JCO.2021.39.3_suppl.34

Abstract #

34

Poster Bd #

Online Only

Abstract Disclosures

Similar Abstracts

First Author: Dalia Kagramanov

First Author: Lauren Victoria Ghazal

Abstract

2022 ASCO Gastrointestinal Cancers Symposium

Prevalence of information needs among emerging and young adult colorectal cancer survivors.

First Author: Serena Yi

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Comparative genomic analysis to identify a signature of sporadic colorectal cancer development in young adults.

First Author: Abedalrhman Alkhateeb